XTANT MEDICAL Revenue vs. Return On Asset
| XMS Stock | EUR 0.34 0.01 3.03% |
For XTANT MEDICAL profitability analysis, we use financial ratios and fundamental drivers that measure the ability of XTANT MEDICAL to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well XTANT MEDICAL HLDGS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between XTANT MEDICAL's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of XTANT MEDICAL HLDGS over time as well as its relative position and ranking within its peers.
XTANT |
XTANT MEDICAL HLDGS Return On Asset vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining XTANT MEDICAL's current stock value. Our valuation model uses many indicators to compare XTANT MEDICAL value to that of its competitors to determine the firm's financial worth. XTANT MEDICAL HLDGS is rated second in revenue category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the XTANT MEDICAL's earnings, one of the primary drivers of an investment's value.XTANT Revenue vs. Competition
XTANT MEDICAL HLDGS is rated second in revenue category among its peers. Market size based on revenue of Medical Devices industry is at this time estimated at about 3.28 Trillion. XTANT MEDICAL adds roughly 56.67 Million in revenue claiming only tiny portion of all equities under Medical Devices industry.
XTANT Return On Asset vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
XTANT MEDICAL |
| = | 56.67 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
XTANT MEDICAL |
| = | -0.0619 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
XTANT Return On Asset Comparison
XTANT MEDICAL is currently under evaluation in return on asset category among its peers.
XTANT MEDICAL Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in XTANT MEDICAL, profitability is also one of the essential criteria for including it into their portfolios because, without profit, XTANT MEDICAL will eventually generate negative long term returns. The profitability progress is the general direction of XTANT MEDICAL's change in net profit over the period of time. It can combine multiple indicators of XTANT MEDICAL, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. XTANT MEDICAL operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people.
XTANT Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on XTANT MEDICAL. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of XTANT MEDICAL position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the XTANT MEDICAL's important profitability drivers and their relationship over time.
Use XTANT MEDICAL in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if XTANT MEDICAL position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTANT MEDICAL will appreciate offsetting losses from the drop in the long position's value.XTANT MEDICAL Pair Trading
XTANT MEDICAL HLDGS Pair Trading Analysis
The ability to find closely correlated positions to XTANT MEDICAL could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace XTANT MEDICAL when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back XTANT MEDICAL - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling XTANT MEDICAL HLDGS to buy it.
The correlation of XTANT MEDICAL is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as XTANT MEDICAL moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if XTANT MEDICAL HLDGS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for XTANT MEDICAL can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your XTANT MEDICAL position
In addition to having XTANT MEDICAL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in XTANT Stock
To fully project XTANT MEDICAL's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of XTANT MEDICAL HLDGS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include XTANT MEDICAL's income statement, its balance sheet, and the statement of cash flows.